BetterScholar BetterScholar
Title Claps Level Year L/Y
GLP1R Gene Expression and Kidney Disease Progression
109 auth. J. L. Triozzi, Zhihong Yu, Ayush Giri, Hua-chang Chen, O. Wilson, B. Ferolito, T. A. Ikizler, Elvis Akwo, C. Robinson-Cohen, J. M. Gaziano, Kelly Cho, Lawrence S Phillips, Ran Tao, Alexandre C Pereira, Adriana M. Hung, ... S. Muralidhar, J. Moser, Jennifer E. Deen, P. Tsao, J. M. Gaziano, Elizabeth R. Hauser, Amy Kilbourne, Michael K. Matheny, Dave Oslin, Lori Churby, S. Whitbourne, J. V. Brewer, S. Shayan, L. Selva, S. Pyarajan, Kelly Cho, S. Duvall, Mary T. Brophy, B. Stephens, Todd Connor, Dean P. Argyres, Tim Assimes, Adriana M. Hung, Henry Kranzler, Samuel M. Aguayo, Sunil K. Ahuja, Kathrina Alexander, Xiao M. Androulakis, Prakash Balasubramanian, Zuhair K. Ballas, J. Beckham, Sujata Bhushan, Edward Boyko, David M. Cohen, Louis J. Dellitalia, L. C. Faulk, Joseph M. Fayad, Daryl Fujii, S. Gappy, Frank Gesek, Jennifer A. Greco, Michael Godschalk, Todd W. Gress, Samir K. Gupta, Salvador Gutierrez, John B. Harley, M. Hamner, Robin A. Hurley, Pran R. Iruvanti, F. Jacono, Darshana Jhala, Scott Kinlay, Michael Landry, Peter Liang, S. Liangpunsakul, Jack Lichy, C. S. Mahan, Ronnie Marrache, Stephen M. Mastorides, Kristin Mattocks, Paul Meyer, J. Moorman, Timothy R. Morgan, Maureen Murdoch, James Norton, O. Okusaga, K. Oursler, Samuel Poon, M. Rauchman, Richard Servatius, Satish C. Sharma, River Smith, P. Sriram, Patrick Strollo, Neeraj Tandon, G. Villareal, Jessica Walsh, J. Wells, Jeffrey Whittle, Mary A Whooley, P. Wilson, Junzhe Xu, S. Yeh, Elizabeth S. Bast, Gerald W Dryden, Daniel J. Hogan, Seema Joshi, Tze Shien Lo, Providencia Morales, Eknath Naik, Michael K. Ong, Ismene Petrakis, Amneet S. Rai, Andrew W. Yen
This genetic association study investigates whether GLP1R gene expression as a proxy for glucagon-like peptide 1 receptor agonists is associated with reductions in kidney disease progression.
This genetic association study investigates whether GLP1R gene expression as a proxy for glucagon-like peptide 1 receptor agonists is associated with reductions in kidney disease progression.
Published in JAMA Network Open
0
0 2024